Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Cardiovascular changes during chronic hypertensive states.

Drozdz D, Kawecka-Jaszcz K.

Pediatr Nephrol. 2014 Sep;29(9):1507-16. doi: 10.1007/s00467-013-2614-5. Epub 2013 Sep 12.

PMID:
24026758
[PubMed - in process]
Free PMC Article
2.

Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.

Swinford RD, Portman RJ.

Adv Chronic Kidney Dis. 2004 Apr;11(2):143-61. Review.

PMID:
15216486
[PubMed - indexed for MEDLINE]
3.

[Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].

Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.

Nefrologia. 2008;28 Suppl 3:39-48. Spanish.

PMID:
19018737
[PubMed - indexed for MEDLINE]
4.

Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Taddei S, Ghiadoni L, Salvetti A.

Drugs. 2003;63(14):1435-44. Review.

PMID:
12834362
[PubMed - indexed for MEDLINE]
5.

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S, Kolloch R, Larochelle P, McInnes GT, Mallion JM, Ruilope L, Wedel H.

J Hypertens. 2001 Jun;19(6):1149-59.

PMID:
11403365
[PubMed - indexed for MEDLINE]
6.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

PMID:
19073656
[PubMed - indexed for MEDLINE]
Free Article
7.

[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].

Oparil S, Bakir SE.

Drugs. 2000;59 Spec No 2:25-37. Review. French.

PMID:
11002856
[PubMed - indexed for MEDLINE]
8.

ACE inhibitors. Differential use in elderly patients with hypertension.

Israili ZH, Hall WD.

Drugs Aging. 1995 Nov;7(5):355-71. Review.

PMID:
8573991
[PubMed - indexed for MEDLINE]
9.

Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.

Alcocer L, Bendersky M, Acosta J, Urina-Triana M.

Am J Cardiovasc Drugs. 2010;10(3):143-54. doi: 10.2165/11536120-000000000-00000. Review.

PMID:
20524716
[PubMed - indexed for MEDLINE]
10.

Prognostic Value of Combined Target-Organ Damage in Patients With Essential Hypertension.

Carpinella G, Pagano G, Buono F, Petitto M, Guarino G, Orefice G, Rengo G, Trimarco B, Morisco C.

Am J Hypertens. 2014 Jun 16. pii: hpu098. [Epub ahead of print]

PMID:
24936579
[PubMed - as supplied by publisher]
11.

Management of hypertension in children with cardiovascular disease and heart failure.

Rad EM, Assadi F.

Int J Prev Med. 2014 Mar;5(Suppl 1):S10-6. Review.

PMID:
24791185
[PubMed]
Free PMC Article
12.

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Kones R.

Drug Des Devel Ther. 2011;5:325-80. doi: 10.2147/DDDT.S14934. Epub 2011 Jun 13. Review.

PMID:
21792295
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Cardioprotection: an essential component for predialysis chronic renal failure treatment].

Jungers P, Qualim Z, Nguyen-Khoa T, Massy Z, London G.

Nephrologie. 2003;24(2):79-88. Review. French.

PMID:
12723513
[PubMed - indexed for MEDLINE]
14.

Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.

Edwards NC, Moody WE, Chue CD, Ferro CJ, Townend JN, Steeds RP.

JACC Cardiovasc Imaging. 2014 Jul;7(7):703-14. doi: 10.1016/j.jcmg.2013.09.025.

PMID:
25034920
[PubMed - in process]
15.

Central blood pressure and pulse wave velocity: relationship to target organ damage and cardiovascular morbidity-mortality in diabetic patients or metabolic syndrome. An observational prospective study. LOD-DIABETES study protocol.

Gómez-Marcos MA, Recio-Rodríguez JI, Rodríguez-Sánchez E, Castaño-Sánchez Y, de Cabo-Laso A, Sánchez-Salgado B, Rodríguez-Martín C, Castaño-Sánchez C, Gómez-Sánchez L, García-Ortiz L.

BMC Public Health. 2010 Mar 18;10:143. doi: 10.1186/1471-2458-10-143.

PMID:
20298558
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Valsartan: more than a decade of experience.

Black HR, Bailey J, Zappe D, Samuel R.

Drugs. 2009;69(17):2393-414. doi: 10.2165/11319460-000000000-00000. Review.

PMID:
19911855
[PubMed - indexed for MEDLINE]
17.

Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.

Levin A.

Semin Dial. 2003 Mar-Apr;16(2):101-5. Review.

PMID:
12641872
[PubMed - indexed for MEDLINE]
18.

Treatment of hypertension in chronic kidney disease.

Toto RD.

Semin Nephrol. 2005 Nov;25(6):435-9. Review.

PMID:
16298269
[PubMed - indexed for MEDLINE]
19.

Renal hypertension and cardiovascular disorder in children with chronic kidney disease.

Peco-Antić A, Paripović D.

Srp Arh Celok Lek. 2014 Jan-Feb;142(1-2):113-7.

PMID:
24684043
[PubMed - in process]
20.

Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.

Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le Maître M, Ortonne JP, Paul C, Richard MA.

J Eur Acad Dermatol Venereol. 2013 Aug;27 Suppl 3:12-29. doi: 10.1111/jdv.12163. Review.

PMID:
23845149
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk